Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

Peer Review reports

Original Submission
20 Mar 2023	Submitted	Original manuscript
8 Apr 2023	Reviewed	Reviewer Report
8 Apr 2023	Reviewed	Reviewer Report
13 Apr 2023	Reviewed	Reviewer Report
10 May 2023	Author responded	Author comments - Sun-Hong Kwon
Resubmission - Version 2
10 May 2023	Submitted	Manuscript version 2
10 May 2023	Author responded	Author comments - Sun-Hong Kwon
Resubmission - Version 3
10 May 2023	Submitted	Manuscript version 3
Publishing
11 May 2023	Editorially accepted
29 May 2023	Article published	10.1186/s12885-023-10950-y

Back to article page